एपीए उद्धरण

Ando, K., Akimoto, K., Sato, H., Manabe, R., Kishino, Y., Homma, T., . . . Sagara, H. (2020). Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer with or without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis. Cancers (Basel).

शिकागो स्टाइल उद्धरण

Ando, Koichi, et al. "Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer With or Without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis." Cancers (Basel) 2020.

एमएलए उद्धरण

Ando, Koichi, et al. "Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer With or Without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis." Cancers (Basel) 2020.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.